Drug Topics staff

The upcoming webinar event “Get to Know Good Neighbor Pharmacy & the Four Core Values” will help independent pharmacies optimize their business and secure their position as a vital source of care in the community. 

The event, which will be held on Tuesday, November 17, will provide actionable insights to help independent pharmacists strengthen their defining attributes by enhancing their current practices. Brought to you by AmerisourceBergen and 

 (GNP), the webinar will equip independent pharmacies with the information they need to improve their performance, develop deeper patient relationships, and secure their legacy within their communities.

Jennifer Zilka, group vice president of GNP’s Field Programs and Services, will introduce viewers to the GNP network and discuss the 4 core value centers pharmacies should focus on:

 Leave a positive impression on every person who walks through your door by using proven tools and expert guidance to deliver the kind of experience your patients are craving.

: Attract more patients and build loyalty by executing proven marketing strategies that showcase your unique brand and extend your reach within your community.

 Maximize profit margin and minimize profit leakage with solutions that combine analytics, technology, and professional services to ensure you get the reimbursement you deserve.

 Perfect how your pharmacy operates with the help of a dedicated business coach who will combine deep industry knowledge with data-driven insight to improve your profitability.

The program aims to provide support where it’s needed most and help pharmacies simplify business operations, amplify brand and identity, and protect their independence.

Articles

Independent pharmacists should tune in to this webinar event to learn how Good Neighbor Pharmacy's 4 core value centers can help them optimize their business. 

Get to Know Good Neighbor Pharmacy and the 4 Core Values

Antibody test.png

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has infected an estimated 39,068,667 individuals worldwide at publishing time, and nearly 8 million Americans. In the latest COVID-19 related news, Kroger Health is offering rapid antibody testing and a recent survey showed wide variation of acceptance rates for a vaccine.

Here’s a roundup of the latest coronavirus-related news:

Kroger Pharmacies to Provide COVID-19 Antibody Tests

Kroger Health is offering rapid antibody testing for COVID-19 across all its pharmacies and clinics by the end of November.

ThoughtSpot 2020 Series: Episode 10: Supporting Marginalized Communities During Natural Disasters

For our first episode in the ThoughtSpot 2020 series, experts from AmerisourceBergen and Healthcare Ready discuss how to support marginalized communities amid pandemics and natural disasters.

Eli Lilly Ends Trial for Bamlanivimab in Hospitalized COVID-19 Patients

Investigators from Eli Lilly’s ACTIV-3 clinical trial investigating bamlanivimab in patients hospitalized with COVID-19 have discontinued the trial after concluding that the therapy showed no benefit. No additional COVID-19 patients in the hospitalized setting will receive bamlanivimab, according to a statement by Eli Lilly.

Survey: Varied Responses on Acceptance of a COVID-19 Vaccine Worldwide

Results of a survey from the City University of New York Graduate School of Public Health and Health Policy showed that acceptance rates of a COVID-19 vaccine varied widely among populations; individuals who reported higher levels of trust in information from their government were more likely to accept a COVID-19 vaccine.

Here's the coronavirus-related news from this week that you should know. 

Coronavirus News Roundup: Kroger to Provide COVID-19 Antibody Tests, Global Survey Assesses COVID-19 Vaccine Acceptance

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has infected an estimated 36,349,500 individuals worldwide, and approximately 7.5 million Americans. The latest COVID-19 related news includes the upcoming MJH Life Sciences COVID-19 Coalition event focused on the treatment landscape, and the dual requests from Regeneron and Eli Lilly for emergency approval for their respective antibody treatments. 

Pharmacists Garner Priority COVID-19 Vaccination in New Recommendations

The new National Academies of Sciences, Engineering, and Medicine's COVID-19 vaccine recommendations identify pharmacists as one of the essential groups that should be the first to receive the vaccines when they are available.

Regeneron, Eli Lilly Both Request Emergency Approval for COVID-19 Antibody Therapies

Both Regeneron and Eli Lilly have filed for emergency use authorization from the FDA for each of their investigational antibody therapies for the treatment of COVID-19.

Navigating the COVID-19 Treatment Landscape: Clinical Controversies Explained

On Tuesday, October 13, MJH Life Sciences™ COVID-19 Coalition will be hosting its next live webinar event “Navigating the COVID-19 Treatment Landscape: Clinical Controversies Explained” at 6 PM EDT.

Election 2020: What Pharmacy Needs from the Next Administration

Scope of practice and vaccination authority don’t usually grab much public attention. But when the US Department of Health & Human Services preempted state practice acts to allow all pharmacists to order and provide COVID-19 tests and provide routine pediatric immunizations, the profession hit the headlines. What happens next in health care depends largely on COVID-19, especially in light of the breaking news at press time that the President has been diagnosed with COVID-19. And then, of course, on the 2020 presidential election itself.

Here's the roundup for this week's coronavirus-related news.

Coronavirus News Roundup: Upcoming MJH COVID-19 Coalition Event, Regeneron and Eli Lilly Request EUA for Antibody Therapies

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID-19), has infected an estimated 34,423,675 individuals worldwide, and approximately 7.3 million Americans. The latest COVID-19 related news includes Moderna’s interim analysis results of its vaccine candidate, and MJH Life Sciences’ COVID-19 Coalition releasing survey results on the most pressing pandemic-related issues.

Moderna COVID-19 Vaccine Elicits Immune Response in Older Adults

Moderna’s COVID-19 vaccine candidate induced immune responses in older adults, according to a second interim analysis of a phase 1 study evaluating safety and immunogenicity.

Experts Weigh in on Latest COVID-19 Pandemic News

 is a partnership with 10 nationally recognized experts in infectious disease, public health, epidemiology, and virology, who work to generate the most accurate, up-to-the-minute information on the pandemic's ever-evolving impact on health care professionals and the patients they treat through live, biweekly webinar events, white papers, and surveys.

Study: Initial SARS-CoV-2 Viral Loads Decreased As Pandemic Progressed

Results of a study based in Detroit, Michigan reported that the initial viral load of SARS-CoV-2 in nasopharyngeal samples has been decreasing throughout the pandemic’s progression.

Here's the coronavirus-related news from this week that you should know.  